innate cell engager (ice®) afm13 combined with cord blood-derived nk cells for r/r cd30 lymphoma
Published 2 years ago • 293 plays • Length 5:02Download video MP4
Download video MP3
Similar videos
-
2:55
afm13 with cord blood-derived nk-cell therapy in patients with refractory cd30-positive lymphomas
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
1:35
redirect results: afm13 in patients with cd30 r/r ptcl
-
2:29
10 years of researching nk-cells for mm treatment
-
1:25
harnessing nk-cells to treat aml
-
1:19
barriers to accessing reni-cel for the treatment of scd
-
3:02
immune system - natural killer cell
-
32:56
echo analyzer monthly maintenance
-
5:16
mek 6400 celltac alpha
-
1:24
phase i study of cd123 nk cell engager sar443579 in r/r aml, b-all or hr-mds
-
1:44
cord blood units for allogeneic cell therapy source material
-
1:43
approval of exa-cel for scd
-
1:57
perspectives on allogeneic nk cell-based immunotherapy
-
51:19
bmsedg 30: red cell immunohaematology (rci): the c-urious jka-se of nocella cellano
-
3:59
3-year follow-up from the transform trial: liso-cel is superior to soc in r/r dlbcl
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
1:03
the growing importance of single-cell rna sequencing in hematology
-
30:15
early detection of hematological cell deviations is now possible
-
2:13
haploidentical sct for the treatment of secondary aml
-
0:38
the functional role of cd4- and cd8-expressing t-cells in aml
-
17:39
non-viral genetic engineering of cytokine-induced killer (cik) cells